01 / Product
Start with the approved storage conditions
Temperature controls should be based on the product’s authorized labeling and stability information, not a generic category assumption. “Refrigerated,” “do not freeze,” “protect from light,” and controlled room temperature each create different packaging and response requirements.
EMA’s GDP guidance emphasizes that medicines must remain in appropriate storage conditions during transportation. Its GMP/GDP questions and answers also state that temperature should be monitored during storage and transport, including for products without a special storage statement on the outer packaging.
02 / Controls
Seven elements of a shipment control plan
| Element | Review question |
|---|---|
| Product profile | What temperature, light, orientation, and handling conditions appear in the approved product information? |
| Packaging | Is the configuration qualified for the product, duration, season, and expected ambient range? |
| Lane | Which airports, hubs, customs points, weekends, and delay scenarios can affect transit? |
| Monitoring | Will a suitable calibrated logger capture relevant temperature fluctuations? |
| Custody | Who owns each handoff, and are storage conditions maintained between handoffs? |
| Receipt | Who retrieves the shipment, reviews the logger, and moves the product into appropriate storage? |
| Excursion | Who quarantines the product and obtains a documented quality disposition before use? |
03 / Packaging
Qualified packaging is route- and season-dependent
A packaging configuration should be supported for a defined payload, ambient profile, duration, and packing procedure. A configuration that works in winter may not protect the same payload during a summer delay. Cool packs can also create freezing risk when placed directly against products that must not freeze.
For a case review, record the pack-out instructions, conditioning method, payload placement, refrigerant arrangement, expected duration, and contingency margin. Photographs are useful evidence of assembly but do not replace qualification data or trained execution.
04 / Monitoring
A data logger creates evidence; it does not decide usability
A temperature logger should be suitable for the expected range and duration, placed in a representative payload position, and tied to the shipment record. The resulting trace needs a defined reviewer and acceptance process.
Quarantine it and obtain an appropriate quality decision using product-specific stability information and the responsible pharmacy, manufacturer, or qualified party.
05 / Border risk
Customs time belongs inside the thermal model
Cross-border logistics adds a variable that domestic parcel estimates often omit: regulatory and customs review can extend transit. A shipment plan should not assume immediate clearance. The intended product and route must first be reviewed for admissibility; thermal packaging cannot make an otherwise unsuitable route acceptable.
US Med Access separates the handling review from the regulatory review, then brings both into the final case assessment. Start with the cold-chain framework and provide the exact product and destination.
Frequently asked questions
Clear answers for the next decision.
01Does express shipping guarantee cold-chain integrity?
No. Speed helps reduce exposure, but integrity also depends on product requirements, qualified packaging, lane risk, monitoring, custody, receipt, and excursion handling.
02Is a temperature logger required for every shipment?
Requirements depend on the product, applicable procedures, and route. A suitable logger is a common way to document fluctuations and support review.
03Can an insulated box with ice packs be considered validated?
Not by itself. The configuration should be supported for the payload, temperature range, duration, season, and assembly procedure.
04What should happen after a temperature excursion?
The product should be quarantined and reviewed using product-specific stability information by the responsible qualified party before any decision to use it.
Primary and authoritative sources
Sources used for this guide
- EMA: Good Distribution Practice
- EMA: GMP/GDP Questions and Answers
- European Commission: Good Manufacturing and Distribution Practices
- USP General Chapter 1079
This page is general information, not medical or legal advice. Requirements and source pages can change; verify the current rule for the specific product and route.